Comparison of neoadjuvant versus upfront surgery for treatment of locally advanced gastric cancer

Main Article Content

Nail Omarov
Derya Salim Uymaz
Bülent Gürbüz
Fatih Selçukbiricik
Orhun Çiğtaşkin
Mesut Yeşilsoy
Emre Özoran
Emre Balik
Dursun Bugra


OBJECTIVE: In this study, we aimed to compare long term oncological outcomes of upfront surgery versus neoadjuvant treatment in patients with locally advanced gastric cancer.

METHODS: A total of 183 patients who were operated for gastric cancer were retrospectively analyzed. The patients received either standard gastrectomy or preoperative NACT + gastrectomy. Neoadjuvant therapy was administered with FLOT regimen (docetaxel, oxaliplatin, fluorouracil, and leucovorin) or DCF regimen (docetaxel, cisplatin, and 5-fluorouracil).

RESULTS: Of the patients receiving NACT, 33 received FLOT regimen and 14 received DCF regimen. The number of male patients was higher in both standard gastrectomy and NACT + gastrectomy groups (p=0.385). Leukopenia and neutropenia were the most common hematological toxicities, while anemia and nausea were the most frequent non-hematological side effects in the both of NACT group. The outcomes of the grades of postoperative complications according to the Clavien-Dindo classification is similar between groups. There was no statistically significant difference in the length of hospital stay after surgery between the groups (p=0,001). According to the disease stage, it was found no statistically significant difference in the OS and DFS between the NACT and standard gastrectomy groups.

CONCLUSION: Although we found no significant difference between the patients undergoing standard gastrectomy and those undergoing NACT before gastrectomy, we believe that NACT may contribute to the favorable prognosis of patients with locally advanced disease with improved OS and DFS and this should be examined in future studies.

Article Details

How to Cite
Omarov, Nail, et al. “Comparison of Neoadjuvant Versus Upfront Surgery for Treatment of Locally Advanced Gastric Cancer”. Annali Italiani Di Chirurgia, vol. 94, no. 6, Nov. 2023, pp. 569-7,